In people with lipodystrophy, either or both of these processes can occur. Metabolic complications can include high levels of fats and sugars in the blood that could lead to the development of other ...

Novelion Therapeutics’ Myalepta (metreleptin) developed for the ultra-rare condition lipodystrophy has been approved by the European Commission, giving patients the first treatment to improve ...